Advancing ATH-1105 for ALS Through Early Clinical and PK Data
Time: 11:00 am
day: Conference Day One Track B
Details:
- Presenting nonclinical pharmacology data supporting clinical translation
- Sharing Phase 1 single and multiple dose healthy volunteer safety and PK data
- Reviewing PK and CSF exposure levels relevant to CNS targeting
- Outlining next steps in clinical development based on early findings
